Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy
Clinical trial NCT03082833 · TERMINATED
Trial details
- NCT number
- NCT03082833
- Sponsor
- Samsung Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-11-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.